ELI LILLY & CO (LLY) Stock Fundamental Analysis

NYSE:LLY • US5324571083

1022.02 USD
-6.81 (-0.66%)
At close: Feb 26, 2026
1020.95 USD
-1.07 (-0.1%)
After Hours: 2/26/2026, 4:21:23 PM
Fundamental Rating

7

Overall LLY gets a fundamental rating of 7 out of 10. We evaluated LLY against 192 industry peers in the Pharmaceuticals industry. While LLY has a great profitability rating, there are some minor concerns on its financial health. LLY is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! LLY also has an excellent dividend rating. These ratings would make LLY suitable for dividend and growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year LLY was profitable.
  • In the past year LLY had a positive cash flow from operations.
  • Each year in the past 5 years LLY has been profitable.
  • LLY had a positive operating cash flow in 4 of the past 5 years.
LLY Yearly Net Income VS EBIT VS OCF VS FCFLLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B

1.2 Ratios

  • The Return On Assets of LLY (16.02%) is better than 95.83% of its industry peers.
  • With an excellent Return On Equity value of 77.38%, LLY belongs to the best of the industry, outperforming 99.48% of the companies in the same industry.
  • LLY's Return On Invested Capital of 28.89% is amongst the best of the industry. LLY outperforms 97.92% of its industry peers.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.89%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LLY Yearly ROA, ROE, ROICLLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • LLY has a better Profit Margin (30.99%) than 94.79% of its industry peers.
  • LLY's Profit Margin has improved in the last couple of years.
  • The Operating Margin of LLY (44.41%) is better than 98.44% of its industry peers.
  • In the last couple of years the Operating Margin of LLY has grown nicely.
  • Looking at the Gross Margin, with a value of 83.03%, LLY belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
  • LLY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
LLY Yearly Profit, Operating, Gross MarginsLLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LLY is creating value.
  • LLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LLY Yearly Shares OutstandingLLY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LLY Yearly Total Debt VS Total AssetsLLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • LLY has an Altman-Z score of 8.18. This indicates that LLY is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of LLY (8.18) is better than 82.29% of its industry peers.
  • LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
  • LLY's Debt to FCF ratio of 6.60 is amongst the best of the industry. LLY outperforms 82.29% of its industry peers.
  • LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of LLY (1.72) is worse than 76.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.18
ROIC/WACC3.16
WACC9.14%
LLY Yearly LT Debt VS Equity VS FCFLLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • LLY has a Current ratio of 1.55. This is in the lower half of the industry: LLY underperforms 70.31% of its industry peers.
  • LLY has a Quick Ratio of 1.24. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.24, LLY is not doing good in the industry: 70.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
LLY Yearly Current Assets VS Current LiabilitesLLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 86.23% over the past year.
  • The Earnings Per Share has been growing by 25.01% on average over the past years. This is a very strong growth
  • Looking at the last year, LLY shows a very strong growth in Revenue. The Revenue has grown by 44.70%.
  • The Revenue has been growing by 21.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%

3.2 Future

  • Based on estimates for the next years, LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 20.61% on average per year.
  • Based on estimates for the next years, LLY will show a quite strong growth in Revenue. The Revenue will grow by 14.73% on average per year.
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y20.61%
Revenue Next Year28.68%
Revenue Next 2Y22.49%
Revenue Next 3Y19.27%
Revenue Next 5Y14.73%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LLY Yearly Revenue VS EstimatesLLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
LLY Yearly EPS VS EstimatesLLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 42.21, LLY can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, LLY is valued a bit cheaper than 77.60% of the companies in the same industry.
  • LLY is valuated expensively when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 30.45, LLY can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, LLY is valued a bit cheaper than 72.92% of the companies in the same industry.
  • LLY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.03.
Industry RankSector Rank
PE 42.21
Fwd PE 30.45
LLY Price Earnings VS Forward Price EarningsLLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • LLY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LLY is cheaper than 78.65% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LLY indicates a somewhat cheap valuation: LLY is cheaper than 75.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 150.11
EV/EBITDA 35.53
LLY Per share dataLLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of LLY may justify a higher PE ratio.
  • LLY's earnings are expected to grow with 23.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.09
PEG (5Y)1.69
EPS Next 2Y31.04%
EPS Next 3Y23.44%

7

5. Dividend

5.1 Amount

  • LLY has a yearly dividend return of 0.68%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.07, LLY pays a better dividend. On top of this LLY pays more dividend than 89.58% of the companies listed in the same industry.
  • With a Dividend Yield of 0.68, LLY pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • On average, the dividend of LLY grows each year by 15.59%, which is quite nice.
  • LLY has paid a dividend for at least 10 years, which is a reliable track record.
  • LLY has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.59%
Div Incr Years10
Div Non Decr Years34
LLY Yearly Dividends per shareLLY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • 28.28% of the earnings are spent on dividend by LLY. This is a low number and sustainable payout ratio.
  • LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
LLY Yearly Income VS Free CF VS DividendLLY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B
LLY Dividend Payout.LLY Dividend Payout, showing the Payout Ratio.LLY Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

NYSE:LLY (2/26/2026, 4:21:23 PM)

After market: 1020.95 -1.07 (-0.1%)

1022.02

-6.81 (-0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners83.09%
Inst Owner Change1.99%
Ins Owners0.16%
Ins Owner Change-3.9%
Market Cap966.20B
Revenue(TTM)65.18B
Net Income(TTM)18.41B
Analysts80.54
Price Target1164.09 (13.9%)
Short Float %0.74%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend4.93
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years10
Div Non Decr Years34
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)3.03%
PT rev (3m)14.02%
EPS NQ rev (1m)-5.48%
EPS NQ rev (3m)-4.39%
EPS NY rev (1m)1.32%
EPS NY rev (3m)7.96%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)2.13%
Revenue NY rev (1m)6.1%
Revenue NY rev (3m)10.67%
Valuation
Industry RankSector Rank
PE 42.21
Fwd PE 30.45
P/S 16.26
P/FCF 150.11
P/OCF 60.15
P/B 40.61
P/tB 84.39
EV/EBITDA 35.53
EPS(TTM)24.21
EY2.37%
EPS(NY)33.56
Fwd EY3.28%
FCF(TTM)6.81
FCFY0.67%
OCF(TTM)16.99
OCFY1.66%
SpS62.85
BVpS25.17
TBVpS12.11
PEG (NY)1.09
PEG (5Y)1.69
Graham Number117.09
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.89%
ROICexc 33.3%
ROICexgc 41.12%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.18
F-Score7
WACC9.14%
ROIC/WACC3.16
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y20.61%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%
Revenue Next Year28.68%
Revenue Next 2Y22.49%
Revenue Next 3Y19.27%
Revenue Next 5Y14.73%
EBIT growth 1Y82.81%
EBIT growth 3Y53.07%
EBIT growth 5Y34.09%
EBIT Next Year43.42%
EBIT Next 3Y24.82%
EBIT Next 5Y21.25%
FCF growth 1Y382.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y166.27%
OCF growth 3YN/A
OCF growth 5YN/A

ELI LILLY & CO / LLY FAQ

Can you provide the ChartMill fundamental rating for ELI LILLY & CO?

ChartMill assigns a fundamental rating of 7 / 10 to LLY.


What is the valuation status of ELI LILLY & CO (LLY) stock?

ChartMill assigns a valuation rating of 5 / 10 to ELI LILLY & CO (LLY). This can be considered as Fairly Valued.


What is the profitability of LLY stock?

ELI LILLY & CO (LLY) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for LLY stock?

The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY) is 42.21 and the Price/Book (PB) ratio is 40.61.


What is the earnings growth outlook for ELI LILLY & CO?

The Earnings per Share (EPS) of ELI LILLY & CO (LLY) is expected to grow by 38.64% in the next year.